Tang Yan-Fen, Wang Yu, Xue Tian-Jiao, Liu Gang, Chen Qi, Zhao Wen, Liu Yan-Yan, Chen Rong-Qian, Chen Li, Liu Jing
Department of Respiratory, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People's Republic of China.
Clinical Key Department of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People's Republic of China.
J Inflamm Res. 2022 Jan 28;15:613-620. doi: 10.2147/JIR.S346200. eCollection 2022.
This study aims to analyze the clinical characteristics of HIV-infected patients complicated with venous thromboembolism (VTE).
Seventy HIV-infected patients complicated with VTE were enrolled from Beijing Ditan Hospital Capital Medical University from October 2009 to December 2020 and divided into two groups according to CD4. The clinical data of 70 patients were observed, including general conditions, laboratory indexes, viral load, antiretroviral therapy (ART) before the diagnosis of VTE, and thrombus treatment.
The patients were divided into two groups according to the CD4 T lymphocyte count. There were 27 patients with a CD4 T lymphocyte count ≥200 cells/ul, classified as group A (27/70, 38.6%), and there were 43 patients with a CD4 T lymphocyte count <200 cells/ul, classified as group B (43/70, 61.4%). In group B, these patients included 37 males and 6 females. The average age was 47.1±12.1 years old. The average levels of the following indexes were: D-dimer, 3.5 mg/L (0.7, 6.9); total cholesterol, 4.4 mmol/L (3.3, 5.5); triglycerides, 1.4 mmol/L (0.9, 2.0); low density lipoprotein, 1.9 mmol/L (1.5,2.5); albumin, 31.8±6.4 g/L; CD4+, 66 cells/ul (18, 127); viral load, 12347 copies/mL (27, 203936). Sixty-three patients (63/70, 90%) had started highly active ART (HAART) before VTE was diagnosed, 37 patients (37/70, 52.9%) were complicated with bacterial pneumonia, 16 patients had (16/70, 22.9%), 13 patients had pneumonia (PCP) (13/70, 18.6%), and eight patients were complicated with cytomegalovirus (CMV) infection (8/70, 11.4%). Twenty-four patients had tumors, and 15 patients had HIV-related tumors (15/70, 21.4%). There were significant differences between the two groups in the time from the diagnosis of HIV to the discovery of thrombosis, the time from ART to the discovery of thrombosis and bacterial pneumonia, and the differences in WBC, PLT, Hb, CRP, PTA, INR, TCHO, LDL-C, ALB, and viral load were statistically significant.
The prevalence of VTE in HIV-infected people in the last 11 years was 1.4%. In patients with a high viral load, CRP, D-dimer levels, and low CD4 and albumin levels, 11.4-22.9% were complicated with an opportunistic infection, and 21.4% had HIV-related tumors. There were significant differences between the two groups in high viral load, CRP, D-dimer, and low albumin.
本研究旨在分析合并静脉血栓栓塞症(VTE)的HIV感染患者的临床特征。
选取2009年10月至2020年12月首都医科大学附属北京地坛医院收治的70例合并VTE的HIV感染患者,根据CD4细胞计数分为两组。观察70例患者的临床资料,包括一般情况、实验室指标、病毒载量、VTE诊断前的抗逆转录病毒治疗(ART)情况及血栓治疗情况。
根据CD4 T淋巴细胞计数将患者分为两组。CD4 T淋巴细胞计数≥200个/微升的患者27例,分为A组(27/70,38.6%);CD4 T淋巴细胞计数<200个/微升的患者43例,分为B组(43/70,61.4%)。B组中,男性37例,女性6例。平均年龄为47.1±12.1岁。以下指标的平均水平分别为:D-二聚体3.5毫克/升(0.7,6.9);总胆固醇4.4毫摩尔/升(3.3,5.5);甘油三酯1.4毫摩尔/升(0.9,2.0);低密度脂蛋白1.9毫摩尔/升(1.5,2.5);白蛋白31.8±6.4克/升;CD4 + 66个/微升(18,127);病毒载量12347拷贝/毫升(27,203936)。63例患者(63/70,90%)在VTE诊断前已开始高效抗逆转录病毒治疗(HAART),37例患者(37/70,52.9%)合并细菌性肺炎,16例患者(16/70,22.9%)合并肺孢子菌肺炎(PCP),13例患者(13/70,18.6%)合并巨细胞病毒(CMV)感染,8例患者(8/70,11.4%)合并肿瘤,15例患者(15/70,21.4%)合并HIV相关肿瘤。两组在从HIV诊断到发现血栓的时间、从ART开始到发现血栓和细菌性肺炎的时间方面存在显著差异,白细胞、血小板、血红蛋白、CRP、PTA、INR、总胆固醇、低密度脂蛋白胆固醇、白蛋白和病毒载量的差异具有统计学意义。
过去11年中HIV感染者VTE的患病率为1.4%。病毒载量高、CRP、D-二聚体水平高且CD4和白蛋白水平低的患者中,11.4% - 22.9%合并机会性感染,21.4%患有HIV相关肿瘤。两组在高病毒载量、CRP、D-二聚体和低白蛋白方面存在显著差异。